(Press-News.org) NEW YORK, February 24, 2026 – The Dana Foundation today announced Walter Koroshetz, M.D., FAAN, will join the organization as a senior advisor, effective March 1, in support of its mission to advance neuroscience that benefits society and reflects the aspirations of all people. Koroshetz, who oversaw the federal government’s largest neuroscience research portfolio as director of the National Institute of Neurological Disorders and Stroke (NINDS), will work with the Foundation’s leadership to guide science funding collaborations and support for early-career scholars and practitioners.
“Having previously worked alongside Walter on the US BRAIN Initiative, International Brain Initiative, and the Global Neuroethics Summit, I’ve seen firsthand his deep commitment to neuroscience that serves society,” said Caroline Montojo, Ph.D., president and CEO of the Dana Foundation. “He champions ethical reflection and societal responsibility and works to actively cultivate those in the next generation. Walter’s ability to galvanize early-career scientists to embrace their role in shaping how neuroscience is used for the public good makes him exceptionally suited for this role.”
“I look forward to contributing to the Foundation’s bold efforts to ensure neuroscience advances meaningfully benefit society,” said Koroshetz. “During my time at NINDS, it was an honor to support scientists, engineers, university collaborators, and early career investigators making extraordinary progress in neuroscience discovery and neurotechnology development. The increasing pace of innovation is bringing new ethical and societal questions to the forefront, underscoring how essential Dana’s mission is at this pivotal moment.”
Koroshetz’s relationship with the Dana Foundation spans many years. He contributed to its earlier work in neuroscience research and public outreach, and in 2020, as the organization refined its mission, he offered perspective on where its support could make the greatest impact—addressing real-world needs through an intersectional approach to neuroscience.
“Walter combines a deep knowledge of neuroscience with the perspective that the field does not operate in a vacuum,” said Steven E. Hyman, M.D., chair of the Dana Foundation Board of Directors. “He shares our commitment to interdisciplinary collaboration, bringing neuroscience into dialogue with fields such as ethics and law to ensure it connects scientific discovery to public impact.”
Koroshetz served as director of the National Institute of Neurological Disorders and Stroke (NINDS) from 2015-26. He joined NINDS in 2007 as deputy director and has held leadership roles in a number of cross-NIH and NINDS programs including co-leading the NIH’s BRAIN Initiative; the NIH RECOVER Initiative on Post Acute Sequelae of COVID-19; the NIH Blueprint for Neuroscience; the TBI Center between the NIH and the Uniformed Health Services University; the Helping to End Addiction Long Term Initiative; and the Accelerated Medicine Partnerships in Parkinson’s and ALS. He also co-led a number of NIH Common Fund’s programs, including the Undiagnosed Disease Network, the Acute to Chronic Pain Transition programs, Somatic Gene Editing program, and Somatic Mosaicism in Human Tissue. Koroshetz founded the BRAIN Initiative Neuroethics Working Group in 2015 and participated as an active member. In 2020, he received the International Neuroethics Society’s Steven E. Hyman Award for Distinguished Service.
Before joining NINDS, Koroshetz served as vice chair of the neurology service and director of stroke and neurointensive care services at Massachusetts General Hospital (MGH). He was a professor of neurology at Harvard Medical School and led neurology resident training at MGH between 1990 and 2007. His early research in the lab and clinic focused on Huntington’s disease, and with the team at MGH performed the first study of pre-symptomatic testing.
***
The Dana Foundation is a private philanthropic organization dedicated to advancing neuroscience and society, a human-centered neuroscience paradigm that connects brain research to real-world needs, values, and experiences. It brings together students, scientists, practitioners, and communities to reflect on assumptions, share expertise, and ensure that neuroscience serves people in meaningful and socially responsible ways.
Media Contact:
Ann Whitman
Director of Communications
awhitman@dana.org
(212) 223-4040 x657
END
“CAR T-cell therapy has emerged as a particularly promising cancer-specific treatment strategy.”
BUFFALO, NY – February 25, 2026 – A new editorial perspective was published in Volume 17 of Oncotarget on February 20, 2026, titled “CAR-T therapy: Trailblazing CAR(ing) in cancer treatment.”
Led by Uzma Saqib — with corresponding author Krishnan Hajela from the School of Life Sciences, Devi Ahilya Vishwavidyalaya — the perspective reviews recent clinical and translational advances in chimeric antigen receptor T-cell (CAR-T) therapy and highlights both its promise ...
Patients are now expected to navigate much of their care online — from seeing their doctor on a screen to booking appointments, refilling prescriptions, and checking test results through health care portals.
Yet, according to a new study by UC San Francisco, most health systems are skipping a crucial step: asking whether their patients have the access and skills to use these digital tools.
The researchers surveyed nearly 150 clinicians and informatics leaders from health care systems across the country during the first half of 2024. Just 44% said they asked their patients if they could use digital devices. Among the ...
Background and objectives
Endometrial polyp (EMP) is one of the most common diagnoses in the evaluation of women with abnormal uterine bleeding. Understanding the malignancy risk associated with EMPs and related risk factors is essential for guiding both pathology practice and clinical management. This study aimed to explore risk factors for malignancy in EMPs.
Methods
The pathology database was searched for women diagnosed with EMP between 2021 and 2022. Patient age, polyp size, background endometrium, recurrence, and (if applicable) cancer types were recorded. Immunohistochemistry (IHC) for p53 and p16 was performed on selected cases. Risk factors for malignancy were analyzed using Chi-square ...
WEST LAFAYETTE, Ind. and MIAMI — Gibson Oncology, a clinical-stage private pharmaceutical company headquartered in Miami, announced it has entered Phase 2 clinical trials with LMP744 for the treatment of first-time recurrent glioblastoma patients.
The company is focused on advancing its novel small molecules with dual-action inhibition of topoisomerase 1 and reduction of overexpression of the cMYC oncogene.
“The primary endpoint of the study is to evaluate tumor regression in patients with recurrent glioblastoma. Secondary endpoints will evaluate parameters such as progression-free survival, biological changes in glioblastoma tissues obtained pre- and post-treatment, ...
Photocatalysts facilitate chemical reactions by absorbing light. Metal-based photocatalysts are widely used in organic synthesis due to their durability and the ability to tune their function by modifying the ligands attached to the central metal atom.
Most metals used in photocatalysts, such as ruthenium and iridium, are rare and expensive. Researchers at Nagoya University, Japan, previously developed an iron-based alternative, but it required large amounts of costly chiral ligands, which act as spatial ...
When researchers studied Norwegians who thought tick bites caused their chronic health problems, they found no objective evidence linking the symptoms to ticks.
The same study finds that health problems reported by participants were associated with little physical activity and low labour force participation.
Many Norwegians pull ticks from their bodies every single summer. Roughly 2 per cent of those who are bitten are infected by a bacterium that leads to Lyme disease.
The disease can start with a rash that eventually spreads in the skin with a ring-shaped pattern. In some people, the disease can develop into facial paralysis, meningitis or other ...
An advanced detection system to identify and trace blockchain funds connected with criminal activity has been presented today at the Annual CyberASAP Demo Day in London.
The system, called SynapTrack, enables faster and more accurate detection of fraudulent activity using blockchains and cryptocurrencies, where traditional anti-money laundering and counter-terrorist financing systems struggle to keep pace.
Although current fraud detection methods pick up unusual activity, they deliver an extremely high rate (40%) of false positive reports. These require manual checking by compliance professionals, resulting in backlogs in identifying and acting ...
Background and objectives
Infectious diarrhea is a gastrointestinal illness that results in around 1.7 billion cases and 525,000 deaths annually, particularly among children under five, according to the World Health Organization. While some Cameroonian medicinal plants show promise for treating diarrhea, many plants are used without established scientific evidence of their efficacy. These plants include Tithonia diversifolia (T. diversifolia) and Solanum torvum (S. torvum), which are traditionally used to treat diarrheal symptoms. This study sought to investigate the anti-Shigella activity of leaf ...
BETHESDA, MD – February 25, 2026 | The ACMG Foundation for Genetic and Genomic Medicine (ACMGF), in partnership with Genetics in Medicine Open (GIM Open), is pleased to announce Qiliang (Andy) Ding, PhD, as the inaugural recipient of the 2026 Rising Scholar Trainee Award. This new annual award recognizes the most outstanding research publication by a trainee published in Genetics in Medicine Open during the preceding calendar year.
The Rising Scholar Trainee Award was established to support early-career investigators and to recognize high-quality scholarly contributions in medical genetics and genomics. Eligible individuals include ...
The Korea Research Institute of Standards and Science (KRISS, President Lee Ho Seong) has developed a next-generation gas sensor technology that uses low-cost and safe LED light to precisely distinguish multiple hazardous gases. Compared with conventional sensors that operate at high temperatures, the new technology consumes significantly less power, offering greater cost efficiency while delivering broad applicability. It is expected to enhance gas safety across industrial settings as well as everyday environments.
Gas sensors currently used in industrial ...
